Loading...
NPI 1336649714 · Arlington, VA · Ambulatory Surgical Clinic/Center
Customize your policy alerts
Get alerted when relevant policies change without checking for updates manually.
Monitor payer policy activity
Healthqare Services Asc LLC is a ambulatory surgical clinic/center provider located in Arlington, Virginia. This profile covers 15 Medicare and 6 Medicaid CPT/HCPCS procedure codes, with claims volume, average reimbursement, and total revenue by code, benchmarked against other providers billing the same services.
Provider details (source: NPPES NPI Registry)
| Field | Value |
|---|---|
| Entity Type | Organization |
| Organization | Healthqare Services Asc LLC |
| Address | 1005 N Glebe Rd Ste 200 |
| City | Arlington |
| State | VA |
| ZIP | 22201 |
| Taxonomy | Ambulatory Surgical Clinic/Center |
| NPI Enumerated | February 13, 2018 |
Lifetime revenue by payer source (source: CMS Medicare & Medicaid claims data)
| Payer Source | Total Paid |
|---|---|
| Medicare | $3.9M |
| Medicaid | $649.8K |
HEALTHQARE SERVICES ASC LLC presents as an ambulatory surgical clinic heavily focused on dialysis access interventions: its top Medicare revenue codes are 36902, 36905, and 36906 which are all dialysis circuit angiography, angioplasty, thrombectomy, and stent placement procedures, indicating the facility primarily provides endovascular dialysis circuit maintenance and salvage services. This operational focus is reinforced by other frequent codes (C7513, 36581, 36558) tied to dialysis circuit imaging and central venous access management.
Medicare revenue is materially larger than Medicaid for this entity: lifetime Medicare revenue is $3.9M versus Medicaid revenue of $649.8K, indicating Medicare is the dominant payer by scale for this provider and that commercial/Medicare populations likely form the core clinical volume. The provider is not effectively single-payer given both payers appear, but Medicare drives the majority of lifetime payments.
Revenue concentration is high on both payers but especially pronounced by payer-specific measures: the precomputed top 3 Medicare codes account for 76.1% of the provider’s total Medicare revenue, concentrating Medicare dollars in a narrow set of dialysis-related endovascular procedures. Medicaid revenue is even more concentrated, with the top 3 Medicaid codes accounting for 97.4% of Medicaid revenue, showing that a very small group of procedure types (notably 36902 and 36581) generate almost all Medicaid receipts.
The provider shows national-level outlier volumes on several Medicare codes, signaling a significant competitive position for specific dialysis procedures: it ranks #1 nationally for 36905 and is in the 100th percentile, is #3 nationally for 36902 and 36906 (100th and 99th percentiles respectively), and is #5 nationally on 36581 (99th percentile). These rank/percentile placements suggest the clinic is a major, exceptionally high-volume national performer for thrombectomy and related dialysis circuit interventions.
Medicaid competitiveness is more localized: although 36902 accounts for 85.0% of this provider’s Medicaid revenue and ranks #5 of 11 providers in-state (60th percentile), other Medicaid high-revenue codes such as 36581 and C7513 rank #1 in-state among very small peer groups, indicating dominance for certain services within Virginia but within a narrow in-state competitive set. In short, the provider is a leading in-state supplier for some Medicaid-coded services but not uniformly across all high-volume Medicaid codes.
Several codes are flagged as statistical outliers or notably above typical national volume on Medicare, and that pattern is visible in the data: labels provided include “extreme outlier” for 36902, 36905, 36581, 36558, and J2997; and “notably above typical national volume” for 36906 and C7513. These descriptors combined with top ranks indicate the provider’s service mix and scale are unusually concentrated in high-acuity dialysis access procedures relative to national peers.
The claim-level averages and claim counts show differing reimbursement intensity across the top Medicare services: high average paid/claim values accompany some lower-claim but high-revenue items (e.g., 36906 at $8612 avg paid/claim and 70 claims), while other high-volume items combine many claims with lower average payments (e.g., 36902 at $1825 avg paid/claim and 748 claims). This pattern implies the provider balances frequent angioplasty/diagnostic work with less frequent but higher-paid device or stent procedures.
Tenure is established but not long-standing: the NPI was enumerated on 2018-02-13 (about 8 years ago), so the clinic has built its billing profile and apparent specialization within a relatively recent operational window, suggesting any recent expansion in dialysis access services would be reflected in this dataset.
Medicare revenue breakdown by CPT/HCPCS procedure code.
View: Bar Chart1 / 2
The CPT/HCPCS codes generating the most Medicare revenue for this provider.
15 rows
| CPT/HCPCS Code | Description | Claims | Avg Paid | Revenue |
|---|---|---|---|---|
| 36902 | The provider introduces a needle and/or catheter under fluoroscopic guidance (live X–rays that can be viewed on a monitor) and injects contrast material into the dialysis access point to visualize… | 750 | $1,830 | $1.4M |
| 36905 | Under fluoroscopic guidance (live X–rays that can be viewed on a monitor), the provider introduces a catheter into a vessel in the dialysis circuit and extracts a blood clot (hematoma) with special… | 210 | $4,680 | $967.9K |
| 36906 | Under fluoroscopic guidance (live X–rays which can be viewed on a monitor), the provider introduces a catheter into a vessel in the dialysis circuit and extracts a blood clot (hematoma) with special… | 70 | $8,610 | $602.8K |
| C7513 | Dialysis circuit, introduction of needle(s) and/or catheter(s), with diagnostic angiography of the dialysis circuit, including all direct puncture(s) and catheter placement(s), injection(s) of… | 380 | $960 | $363.3K |
| 36903 | The provider introduces a needle and/or catheter under fluoroscopic guidance (live X–rays that can be viewed on a monitor) and injects contrast material into the dialysis access point to visualize… | 30 | $5,460 | $174.8K |
| 36581 | This procedure is a complete replacement of a tunneled CVA catheter in cases of blockage, damage, or malfunction. | 110 | $1,390 | $151K |
| 36558 | The provider places a catheter, without a subcutaneous port or pump in one of the major veins carrying the blood to the heart or directly into the right atrium, to administer medication, nutrients,… | 60 | $1,060 | $60.4K |
| J2997 | Injection, alteplase recombinant, 1 mg | 530 | $70 | $37.1K |
| 36475 | In this procedure, the provider inserts a specially designed radiofrequency probe through the skin and destroys the wall of a diseased vein in an extremity. The provider reports this code for… | 30 | $1,150 | $32.1K |
| C7514 | Dialysis circuit, introduction of needle(s) and/or catheter(s), with diagnostic angiography of the dialysis circuit, including all direct puncture(s) and catheter placement(s), injection(s) of… | 30 | $1,040 | $30K |
Showing 1–10 of 15
How this provider's Medicare billing volume and revenue compare to other providers nationally and within its state, across 15 CPT/HCPCS codes.
View: State1 / 2
Full comparison — all codes billed, vs. state median
15 rows
| CPT/HCPCS Code | Rank | Provider Count | Median Claims | Avg Paid | Average Revenue |
|---|---|---|---|---|---|
| C7513 | 1 | 10 | 230 | $950 | $213.1K |
| 36906 | 1 | 10 | 30 | $4,950 | $158.4K |
| 36905 | 1 | 20 | 30 | $2,190 | $105.1K |
| 36902 | 1 | 60 | 30 | $860 | $71.8K |
| 36903 | 2 | 10 | 20 | $3,000 | $69.1K |
| 36475 | 17 | 30 | 30 | $820 | $39.5K |
| C7514 | 1 | 10 | 30 | $1,040 | $30K |
| 37246 | 4 | 10 | 20 | $1,100 | $28.5K |
| 36581 | 2 | 20 | 20 | $580 | $22.6K |
| 36901 | 8 | 30 | 20 | $290 | $12.4K |
Showing 1–10 of 15
Medicaid revenue breakdown by year and by CPT/HCPCS procedure code, including monthly billing trends and the top codes driving revenue.
View: By Year1 / 3
Every CPT/HCPCS code this provider has billed to Medicaid, with claims volume, average payment, and total revenue.
6 rows
| CPT/HCPCS Code | Description | Claims | Avg Paid | Revenue |
|---|---|---|---|---|
| 36902 | The provider introduces a needle and/or catheter under fluoroscopic guidance (live X–rays that can be viewed on a monitor) and injects contrast material into the dialysis access point to visualize… | 2,150 | $260 | $551.8K |
| 36581 | This procedure is a complete replacement of a tunneled CVA catheter in cases of blockage, damage, or malfunction. | 120 | $420 | $49.2K |
| C7513 | Dialysis circuit, introduction of needle(s) and/or catheter(s), with diagnostic angiography of the dialysis circuit, including all direct puncture(s) and catheter placement(s), injection(s) of… | 350 | $90 | $31.2K |
| 36905 | Under fluoroscopic guidance (live X–rays that can be viewed on a monitor), the provider introduces a catheter into a vessel in the dialysis circuit and extracts a blood clot (hematoma) with special… | 60 | $270 | $14.8K |
| 36901 | The provider introduces a needle and/or catheter under fluoroscopic guidance (live X–rays that can be viewed on a monitor) and injects intravenous contrast material to visualize and record images of… | 30 | $50 | $1.4K |
| 36589 | In this procedure, the provider removes a tunneled central venous access device without the subcutaneous port or pump. | 10 | $40 | $620 |
How this provider's Medicaid billing volume and revenue compare to other Virginia providers billing the same CPT/HCPCS codes.
Full comparison — all codes billed, vs. Virginia median
6 rows
| CPT/HCPCS Code | Description | Rank | Provider Count | Median Claims | Avg Paid | Average Revenue |
|---|---|---|---|---|---|---|
| 36902 | The provider introduces a needle and/or catheter under fluoroscopic guidance (live X–rays that can be viewed on a monitor) and injects contrast material into the dialysis access point to visualize… | 5 | 10 | 1,810 | $210 | $328.7K |
| 36901 | The provider introduces a needle and/or catheter under fluoroscopic guidance (live X–rays that can be viewed on a monitor) and injects intravenous contrast material to visualize and record images of… | 3 | 10 | 530 | $120 | $51.7K |
| 36581 | This procedure is a complete replacement of a tunneled CVA catheter in cases of blockage, damage, or malfunction. | 1 | 10 | 70 | $430 | $28.7K |
| C7513 | Dialysis circuit, introduction of needle(s) and/or catheter(s), with diagnostic angiography of the dialysis circuit, including all direct puncture(s) and catheter placement(s), injection(s) of… | 1 | 10 | 190 | $90 | $16.2K |
| 36905 | Under fluoroscopic guidance (live X–rays that can be viewed on a monitor), the provider introduces a catheter into a vessel in the dialysis circuit and extracts a blood clot (hematoma) with special… | 1 | 10 | 40 | $240 | $8.8K |
| 36589 | In this procedure, the provider removes a tunneled central venous access device without the subcutaneous port or pump. | 5 | 10 | 20 | $230 | $7.8K |
Other providers in the same ZIP code as Healthqare Services Asc LLC, ranked by combined Medicare and Medicaid revenue.
| Provider | State | Taxonomy | Medicare Revenue | Medicaid Revenue |
|---|---|---|---|---|
| Arlington County Government Department Of Managment & Finance | VA | Ambulance | $1.3M | $1.5M |
| Isabelle Le | VA | Hematology & Oncology Physician | $1M | $0 |
| Patricia Rodriguez | VA | Hematology & Oncology Physician | $989.1K | $0 |
| John Feigert | VA | Hematology & Oncology Physician | $925.9K | $0 |
| Robert Christie | VA | Hematology & Oncology Physician | $885.7K | $0 |
| Keeran Sampat | VA | Hematology & Oncology Physician | $848.7K | $0 |
| Raymond Vlacancich | VA | Cardiovascular Disease Physician | $644.3K | $0 |
| Antonio Parente | VA | Cardiovascular Disease Physician | $317.1K | $0 |
| Thomas Raggio | VA | Vascular & Interventional Radiology Physician | $245.8K | $0 |
| Christopher Mcmanus | VA | Internal Medicine Physician | $102.1K | $0 |
Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.